Cannabidiol CBD

A potent and selective CB1 receptor antagonist/inverse agonist (Ki = 12 and 4,200 nM for CB1 and CB2, respectively)

A potent and selective CB1 receptor antagonist/inverse agonist (Ki = 12 and 4,200 nM for CB1 and CB2, respectively)

Application AM630 has been used: as a cannabinoid 2(CB2) inhibitor to study the analgesic effect exerted by polysaccharopeptide from&nbsp: Trametes versicolor (TPSP). as a CB2 antagonist along with &#946:-caryophyllene (BCP) to study its

Application AM630 has been used: as a cannabinoid 2(CB2) inhibitor to study the analgesic effect exerted by polysaccharopeptide from&nbsp: Trametes versicolor (TPSP). as a CB2 antagonist along with &#946:-caryophyllene (BCP) to study its

Immunogen fusion protein containing amino acids 1-99 of the human CB1 receptor. Application Anti-Cannabinoid Receptor 1 antibody produced in rabbit is suitable for western blotting at a working dilution of 1:250 and for immunocytochemistry at a

Cannabinoid receptor type 1 (CNR1) is a G protein-coupled cannabinoid receptor found in central and peripheral nervous system. CNR1 belongs to rhodopsin-like G protein-coupled receptor superfamily.

CB1 is a protein that is one of two cannabinoid receptors (CB1 CB2). Cannabinoid principally delta-9-tetrahydrocannabinol (THC) and its synthetic analogs, are the active psychoactive compounds present is marijuana.

Specificity Recognizes human Cannabinoid Receptor 1 (CB1). The immunogen shows no significant sequence homology with CB2 or other receptors.

Specificity Recognizes Cannabinoid Receptor 1 [CB1]. Immunogen Synthetic peptide from the 3rd cytoplasmic domain of human Cannabinoid Receptor 1.

General description Anti-CNR1 Antibody detects endogenous levels of total CNR1 protein. CNR1 (cannabinoid receptor 1) is a member of the class A G protein-coupled receptor (GPCR) family.

Anti-CNR1 cannabinoid receptor 1, 25ul UN 1687 6.1 PG2

Anti-NACC1 nucleus accumbens associated 1, BEN and BTB (POZ)